A validated UHPLC-MS/MS method for simultaneous quantification of some repurposed COVID-19 drugs in rat plasma: Application to a pharmacokinetic study

Since the emergence of Corona virus disease (COVID-19) in 2019, a number of medications have been developed and tried to combat the pandemic. In the present study, we develop a LC-MS/MS approach to detect and quantify certain COVID-19 candidate drugs in rat plasma, including Hydroxychloroquine, Favi...

Descripción completa

Detalles Bibliográficos
Autor principal: El Azab, Noha F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891122/
https://www.ncbi.nlm.nih.gov/pubmed/35261396
http://dx.doi.org/10.1016/j.microc.2022.107321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891122/
https://www.ncbi.nlm.nih.gov/pubmed/35261396
http://dx.doi.org/10.1016/j.microc.2022.107321

Ejemplares similares